CD19 CAR circRNA, expressing CD19 car protein, is utilized in chimeric antigen receptor T cell immunotherapy (CAR-CD19). This compound involves a chimeric antigen receptor, CD19, a CD molecule present on B cells (i.e., leukocyte differentiation antigen), crucial for B cell proliferation, differentiation, activation, and antibody production, and facilitates BCR signal transduction.
Target:
Immunology/Inflammation related|||Others
* VAT and and shipping costs not included. Errors and price changes excepted
